Prostaglandin analogue

(redirected from Prostaglandin analogs)

Prostaglandin analogue

A class of drugs that are similar in structure and function to prostaglandin.
Mentioned in: Glaucoma
References in periodicals archive ?
2% (BBFC) used Adjunctive to Prostaglandin Analogs (PGAs): Findings show additive effect of BBFC therapy in patients with open-angle glaucoma or ocular hypertension who were inadequately controlled on PGA alone.
Many prescription eye drops, including prostaglandin analogs or look-alikes such as latanoprost, are believed to lower pressure within the eyes by increasing fluid outflow.
and foreign patent owner, Allergan obtains the rights to the use of bimatoprost and other prostaglandins and prostaglandin analogs as a treatment to stimulate eyelash growth.
Topical prostaglandin analogs (Lumigan) increase the flow of fluid out of the eye.
These include prostaglandin analogs such as prostacyclin and low-dose inhaled nitric oxide.
As discussed in more detail below, the use of prostaglandin analogs presents additional safety risks to the woman as compared to RU 486 used as a single-agent abortifacient.
The recently released TreatmentTrends[R]: Glaucoma report finds that the prostaglandin analogs continue to be the most commonly prescribed drug class for the treatment of glaucoma, with 71 percent of pharmacologically-treated patients prescribed at least one of the prostaglandin agent.
Bauman has also been at the forefront of Low Level Laser Therapy for hair growth, topical prostaglandin analogs, Platelet Rich Plasma (PRP), Body Hair Transplantation (BHT), genetic hair loss testing, pharmacy compounded Formula 82M minoxidil, Cross-Sectional Hair Bundle Trichometry using HairCheck and Social Media.
Nevertheless, Pfizer has reaffirmed its commitment to the ongoing joint research program with NicOx, which aims to identify the most active nitric oxide-donating prostaglandin analogs for development on a global basis.
The dose should not exceed once daily since it has been shown that more frequent administration of prostaglandin analogs may lessen the IOP lowering effect.
Pharmacia intends to vigorously enforce its vast array of intellectual property in the ophthalmology field, including prostaglandin analogs, and is confident that all of its intellectual property is valid and enforceable.
While respondents anticipate continued use of prostaglandin analogs for the majority of their patients with POAG, Lumigan 0.